Symbicort Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)
Condition:   Asthma Interventions:   Drug: BFF MDI 160/9.6 μg BID (320/19.2μg/day);   Drug: BD MDI 160 μg BID (320 μg/day) Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials

A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)
Condition:   Asthma Interventions:   Drug: BFF MDI 160/9.6 μg BID (320/19.2μg/day);   Drug: BD MDI 160 μg BID (320 μg/day) Sponsor:   AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials

Non-Inferiority,Combination Formoterol/FluticasonexAlenia ®Formoterol/Budesonide for Asthma in Brazil
Condition:   Moderate Asthma Interventions:   Drug: Administration of investigation drug;   Drug: Administration of comparator Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials